Nick Woolf, Chief Business Officer
Nick Woolf, age 40, was appointed to the board of Oxford BioMedica in March 2005 and was appointed Chief Business Officer in July 2008. He has extensive experience in investment banking and equity research in the biotechnology and pharmaceutical sectors. Nick joined Oxford BioMedica in 2002 from ABN AMRO, where he was a Director and Head of European Biotechnology Research. Prior to ABN AMRO, he was a Vice President and Senior European Biotechnology Analyst at Robertson Stephens, and was previously at Nomura and SBC Warburg. Nick is a qualified FCCA accountant and holds an MA in Chemistry from the University of Oxford
Nick Woolf, Chief Business OfficerNick Woolf, age 40, was...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |